Statistics for CRISPR Therapeutics AG (id:6407 CRSP)
Valuation metrics
Market cap
3.47B
Enterprise value
1.74B
Trailing P/E (ttm)
-20.99
Forward P/E
-8.08
PEG ratio
-8.08
Price/Sales (ttm)
17.13
Price/Book (mrq)
1.79
Enterprise Value/Revenue
8.57
Enterprise Value/EBITDA
-5.55
Overview
Shares outstanding
85.35M
Float
83.90M
Shares short
18.15M
% Held by insiders
5.00%
% Held by institutions
3.00%
Average volume (10 days)
1.82M
Average volume (90 days)
Price summary
52-Week low
39.41
52-Week high
91.10
52-Week change
-60.44%
Beta
1.66
50-Day moving average
48.46
200-Day moving average
54.03
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
-118.13%
Operating margin
-18,294.02%
Operational effectiveness
Return on assets
-9.57%
Return on equity
-13.07%
Income statement
Revenue (ttm)
2.45
Revenue per share (ttm)
2.45
Quarterly revenue growth (yoy)
Gross profit (ttm)
239.75M
EBITDA
-313,078,016.00
Net income to common (ttm)
-239,594,000.00
Diluted EPS (ttm)
-2.79
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
1.94B
Total cash per share (mrq)
22.68
Total debt (mrq)
227.54M
Total Debt/Equity (mrq)
11.73
Current ratio (mrq)
2.16K%
Book value per share (mrq)
22.73
Cash flow
Cash flow statement
-188,816,000.00
Levered free cash flow (LFCF)
-118,566,872.00